EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, K.-M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Keller, K.-M.
Evidence-Based Medicine 2003; 8:177
© 2003 BMJ Publishing Group Ltd.


Therapeutics

Review: famotidine, pizotifen, cognitive behavioural therapy, and peppermint may be effective in recurrent abdominal pain

Weydert JA, Ball TM, Davis MF.Systematic review of treatments for recurrent abdominal pain.Pediatrics 2003;111:e1–11[Abstract/Free Full Text]

QUESTION: In children, what is the effectiveness of treatments for recurrent abdominal pain (RAP)?

Key Words: abdominal pain • famotidine • pain measurement • pizotyline • behaviour therapy • plant oils

The first 150 words of the full text of this article appear below.

Data sources
Studies were identified by searching Medline (1966 to 2001), the Cochrane Clinical Trial registry, the Cochrane Database of Systematic Reviews, AMED, PsycINFO, and PubMed via the National Center for Complementary and Alternative Medicine; and by reviewing bibliographies of relevant articles using terms including recurrent abdominal pain, functional abdominal pain, irritable bowel syndrome, children, and alternative therapies.

Study selection
English language randomised controlled trials (RCTs) were selected if they were done on children aged <=18 years with a diagnosis of RAP. Studies not on functional gastrointestinal disorders, and those lacking a control group were excluded.

Data extraction
Data were extracted on participants’ characteristics and heterogeneity, study quality and design, interventions, outcomes, and a study’s adherence to the standardised case definition of RAP (>=3 episodes of abdominal pain occurring over >=3 mo and severe enough to interfere with normal activities).

Main results
10 trials met the inclusion criteria and all studies stated that they were blinded. 2 . . . [Full text of this article]

Klaus-Michael Keller, MD, Professor Dr

Deutsche Klinik fur Diagnostik
Aukammallee, Wiesbaden, Germany







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.